Sonarab L 75mg/20mg Capsule SR
Manufacturer
Coniak Lifesciences
Salt Composition
Levosulpiride (75mg) + Rabeprazole (20mg)
Key Information
Short Description
Sonarab L 75mg/20mg Capsule SR is a prescription medicine used to treat gastroesophageal reflux disease (acid reflux), intestinal ulcers, and irritable bowel syndrome.
Dosage Form
Capsule SR
Introduction
Sonarab L 75mg/20mg Capsule SR is a combination of two medicines: Levosulpiride and Rabeprazole. It reduces excess acid production in the stomach and prevents the reflux of stomach acid into the food pipe. It is taken with or without food in a dose and duration as advised by the doctor. The dose you are given will depend on your condition and how you respond to the medicine. You should keep taking this medicine for as long as your doctor recommends.
Directions for Use
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Sonarab L 75mg/20mg Capsule SR is to be taken empty stomach.
Safety Information
Side Effects
The most common side effects are nausea stomach pain diarrhea flatulence constipation headache weakness and flu-like symptoms.
Alcohol Warning
It is unsafe to consume alcohol with Sonarab L 75mg/20mg Capsule SR.
Breastfeeding Warning
Information regarding the use of Sonarab L 75mg/20mg Capsule SR during breastfeeding is not available. Please consult your doctor.
Pregnancy Warning
Sonarab L 75mg/20mg Capsule SR may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
How it works
Sonarab L 75mg/20mg Capsule SR is a combination of two medicines: Levosulpiride and Rabeprazole.
Quick Tips
It is a well-tolerated medicine and provides relief for a long time. Take it one hour before the meal preferably in the morning. Inform your doctor if you get watery diarrhea fever or stomach pain that does not go away. Do not consume alcohol while taking Sonarab L 75mg/20mg Capsule SR as it can increase the risk of stomach damage. Long-term use may cause weak or broken bones. Take adequate intake of dietary calcium and vitamin D or their supplements.
Related Medicines
Acera-L Capsule SR
Veloz L Capsule
Rabonik Plus Capsule SR
Rabemac LS Capsule
Rablet L Capsules
Ansuper-Plus Capsule SR
Colosafe-L Capsule SR
Razo-L Capsule
Robeen-L Capsule SR
Rabilius L 75mg/20mg Capsule SR
Frequently asked questions
What is the recommended dosing schedule for Sonarab L 75mg/20mg Capsule SR?
Take one capsule of Sonarab L 75mg/20mg Capsule SR daily, on an empty stomach.
Are there any contraindications associated with the use of Sonarab L 75mg/20mg Capsule SR?
Sonarab L 75mg/20mg Capsule SR should not be used by patients with known allergies to any of its components or excipients.
Can Sonarab L 75mg/20mg Capsule SR cause dizziness in some individuals?
Yes, some individuals may experience dizziness (feeling faint, weak, unsteady or lightheaded) while taking Sonarab L 75mg/20mg Capsule SR. If you experience dizziness, it is advisable to rest and resume your activities once the symptoms subside.
Does prolonged use of Sonarab L 75mg/20mg Capsule SR increase the risk of fractures?
Some studies in adults have indicated a potential increased risk of osteoporosis-related fractures, specifically hip, wrist, or spine fractures, when taking high doses of Sonarab L 75mg/20mg Capsule SR. The increased fracture risk is linked to long-term therapy (over a year), and frequent doses.
Can I drive while taking Sonarab L 75mg/20mg Capsule SR?
Taking Sonarab L 75mg/20mg Capsule SR may cause drowsiness or dizziness. It is essential to refrain from driving or operating machinery until you fully understand its effects on your body.
What are the storage and disposal instructions for Sonarab L 75mg/20mg Capsule SR?
Store Sonarab L 75mg/20mg Capsule SR in a sealed container, as instructed by the packaging. Do not allow animals, children, or other individuals to access it.
